Call for Papers  

Article Details

Review Article

Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma


Tennyson P Rayginia, Chenicheri K. Keerthana, Sadiq C. Shifana, Maria Joy P, Ajmani Abhishek and Ruby Anto*   Pages 1 - 23 ( 23 )


Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, accounting for 85-90% of liver cancer cases and is a leading cause of cancer-related mortality worldwide. The major risk factors for HCC include hepatitis C and B viral infections, along with chronic liver diseases, such as cirrhosis, fibrosis, and non-alcoholic steatohepatitis associated with metabolic syndrome. Despite the advancements in modern medicine, there is a continuous rise in the annual global incidence rate of HCC, and it is estimated to reach >1 million cases by 2025. Emerging research in phytomedicine and chemotherapy has established the anti-cancer potential of phytochemicals, owing to their diverse biological activities. In this review, we report the major phytochemicals that have been explored in combating hepatocellular carcinoma and possess great potential to be used as an alternative or in conjunction with the existing HCC treatment modalities. An overview of the pre-clinical observations, mechanism of action and molecular targets of some of these phytochemicals is also incorporated.


Liver cancer,cell signalling,chemopreventives,chemotherapeutics,chemosensitization,Hepatocellular carcinoma


Read Full-Text article